# Vitamin E and N-acetylcysteine for Preventing Contrast-Induced Acute Kidney Injury After Coronary Artery Catheterization

Study · id `cardio:ct-nct03755700` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03755700](<https://clinicaltrials.gov/study/NCT03755700>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03755700

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1000 participants.

## Technical summary

Registry record NCT03755700. Randomized; double masking; primary purpose prevention. Start 2018-11-01 (actual); primary completion 2019-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose prevention
- Phase: Phase 3
- Enrolled: 1000 participants (planned count; ClinicalTrials.gov record NCT03755700, source copy `cardio:ctgov-nct03755700-2018-11-30`, retrieved 2026-10-26)
- Started: 2018-11-01 (actual) (ClinicalTrials.gov record NCT03755700, source copy `cardio:ctgov-nct03755700-2018-11-30`, retrieved 2026-10-26)
- Primary completion: 2019-12-31 (anticipated) (ClinicalTrials.gov record NCT03755700, source copy `cardio:ctgov-nct03755700-2018-11-30`, retrieved 2026-10-26)
- Completion: 2019-12-31 (anticipated) (ClinicalTrials.gov record NCT03755700, source copy `cardio:ctgov-nct03755700-2018-11-30`, retrieved 2026-10-26)
- Countries: Iran (ClinicalTrials.gov record NCT03755700, source copy `cardio:ctgov-nct03755700-2018-11-30`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03755700-2018-11-30`, retrieved 2026-10-26)

## The registry's words

- Brief title: Vitamin E and N-acetylcysteine for Preventing Contrast-Induced Acute Kidney Injury After Coronary Artery Catheterization
- Condition: Coronary Artery Disease
- Condition: Coronary Artery Angiography
- Condition: Coronary Catheterization
- Condition: Contrast-induced Nephropathy
- Condition: Stable Angina
- Condition: Acute Coronary Syndrome
- Intervention (Drug): Vitamin E
- Intervention (Drug): N-acetyl cysteine
- Intervention (Drug): Placebo oral capsule
- Intervention (Drug): Placebos
- Intervention (Drug): Normal Saline Flush, 0.9% Injectable Solution
- Lead sponsor: Rajaie Cardiovascular Medical and Research Center
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Stable angina (`cardio:stable-angina`)
- Registry lists this organization as the lead sponsor: Rajaie Cardiovascular Medical and Research Center (`cardio:org-rajaie-cardiovascular-medical-and-research-center`)

## Provenance

Content hash: f4684e3afcc5abbd4ef6885e88c574994d66d8b285b75f60da39c90e7a50ed02
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
